
Artificial intelligence may be transforming drug discovery, but AI is only as powerful as the data it learns from. Behind many of today's scientific breakthroughs sits an invisible layer of expertly curated, harmonized knowledge that allows researchers to ask better questions and trust the answers. In this episode, Rafael speaks with Tim Walberg, President of CAS, about why scientific data curation remains essential in the age of large language models, how CAS has evolved from Chemical Abstracts Service into a global scientific intelligence platform, and why the future of AI in science depends as much on data quality as on model sophistication.TPM E60 highlights >Episode 60 links:CASAmerican Chemical Society (ACS)CAS SciFinderCAS BioFinder
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

Andrii Buvailo | The Kodak moment for drug discovery: AI, adaptation, and what stays human | TPM podcast #61

Jacob Hooker | From motifs to medicines: Harnessing nature’s pharmacopeia for novel CNS therapies | TPM podcast #59

James Zanewicz | Fostering innovation at scale: it’s all about the ecosystem | TPM podcast #58

Lisa Gurry | To Infinity and beyond: the future of comprehensive testing and genetic medicine | TPM podcast #57
Free AI-powered recaps of Talking Precision Medicine and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.